Skip to main content
ADIM logo

ADIM — Investor Relations & Filings

Ticker · 4142 ISIN · TW0004142005 LEI · 549300M5TV8YGVXU1827 TW Manufacturing
Open in API
Filings indexed 1,804 across all filing types
Latest filing 2024-03-13 Regulatory Filings
Country TW Taiwan
Listing TW 4142

About ADIM

http://www.adimmune.com.tw/

ADIMMUNE CORPORATION, established in 1965, specializes in the research, development, and large-scale manufacturing of human vaccines and biologics. The company is a primary supplier of seasonal influenza and tetanus vaccines, maintaining production facilities that adhere to PIC/S GMP, US FDA, and EU standards. Its operations encompass the full product lifecycle, from initial R&D to commercial distribution. In addition to its proprietary vaccine portfolio, the company provides Contract Development and Manufacturing Organization (CDMO) services, supporting collaborative development and global supply chains. Recognized for its technical expertise in viral and bacterial vaccine production, the organization focuses on delivering high-quality immunization solutions to international markets while leveraging its history as a pioneering vaccine laboratory.

Recent filings

Filing Released Lang Actions
112年12月營業收入
Regulatory Filings Classification · 90% confidence The document is a financial summary report showing monthly and cumulative net operating revenue figures for a company named 國光生 for December 2023 (民國112年12月). It includes percentage changes compared to the previous year and explanations for revenue changes. The document is short (808 characters) and appears to be a regulatory disclosure of revenue figures rather than a full financial report. It does not contain comprehensive financial statements or detailed analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). It is more consistent with a Regulatory Filing (RNS) as it provides a brief financial update and explanatory notes without full financial statements or management discussion. Therefore, the best classification is Regulatory Filings (RNS).
2024-03-13 Chinese
112年12月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company (國光生) providing information about fund lending balances and endorsement guarantees for the current and previous months, with all values reported as zero. The content is concise, factual, and regulatory in nature, without detailed financial statements or analysis. It does not represent a full financial report but rather a regulatory compliance disclosure. Given the short length (602 characters) and the nature of the content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-03-13 Chinese
公告本公司董事會通過112年度合併財務報告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a listed company (國光生) reporting that the board of directors has approved the consolidated financial report for the fiscal year 112 (2023). It includes summarized financial data such as revenue, gross profit, operating loss, net loss, total assets, liabilities, and equity for the full year period 112/01/01 to 112/12/31. The document is short (902 characters) and appears to be a formal announcement of the board's approval of the annual consolidated financial report rather than the full annual report itself. There is no detailed financial statement or comprehensive analysis present, only key financial figures and approval dates. This fits the profile of a Regulatory Filing (RNS) as it is a regulatory announcement of the approval of the annual financial report, not the full Annual Report (10-K) itself.
2024-03-13 Chinese
董事會決議不分派股利
Regulatory Filings Classification · 95% confidence The document is a formal announcement from the company's legal officer regarding a board resolution not to distribute dividends for the fiscal year 112 (2023). It specifies details about the dividend distribution, all of which are zero, indicating no dividend payout. The document is short (749 characters) and is a regulatory announcement about dividend decisions rather than a detailed financial report or dividend payment notice. It does not contain actual financial statements or detailed analysis, nor does it announce dividend amounts or payment dates (all are zero). Therefore, it fits best under the category of Regulatory Filings (RNS) as a formal disclosure of board decisions related to dividends but not a Notice of Dividend Amount (DIV) since no dividend is declared.
2024-03-13 Chinese
112年度股利金額(董事會決議)
Notice of Dividend Amount Classification · 100% confidence The document text is a detailed announcement of dividend distribution information for a company, including dividend amounts, dates, and related notes. It does not contain a full financial report or comprehensive financial statements. The content focuses specifically on dividend amounts and payment details, which aligns with the definition of a Notice of Dividend Amount (DIV). The document length is under 5,000 characters and is not a report publication announcement or a certification. Therefore, the appropriate classification is Notice of Dividend Amount (DIV).
2024-03-13 Chinese
公告本公司董事會決議召開113年股東常會日期及相關事宜
AGM Information Classification · 95% confidence The document is a formal announcement from the company 國光生 (Guoguang Bio) regarding the board resolution to convene the Annual General Meeting (AGM) for the year 113 (Taiwan calendar year, corresponding to 2024). It includes details such as the date and location of the AGM, agenda items including the 112th fiscal year business report and financial statements, election of an independent director, and other procedural matters. The document is short (1038 characters) and serves as a notification of the AGM date and related matters rather than the actual AGM materials or reports. Therefore, it fits the category of AGM Information (AGM-R) which covers presentations and materials shared during or about the AGM, specifically the announcement of the AGM date and agenda.
2024-03-13 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.